Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1987-5-21
|
pubmed:abstractText |
The experience with the treatment of malignant histiocytosis has been disappointing. Despite modest treatment success with a combination of cyclophosphamide, Adriamycin (doxorubicin), vincristine and prednisone, the overall prognosis remains poor. There are only a few reports of prolonged complete remissions in pediatric patients. The following report describes two children who have had long-term remission with an aggressive combination chemotherapy program that included intrathecal prophylaxis. The chemotherapeutic regimen described merits further evaluation in a larger number of patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1566-70
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3828956-Adolescent,
pubmed-meshheading:3828956-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:3828956-Child,
pubmed-meshheading:3828956-Drug Administration Schedule,
pubmed-meshheading:3828956-Female,
pubmed-meshheading:3828956-Histiocytic Sarcoma,
pubmed-meshheading:3828956-Humans,
pubmed-meshheading:3828956-Lymph Nodes,
pubmed-meshheading:3828956-Male
|
pubmed:year |
1987
|
pubmed:articleTitle |
Malignant histiocytosis. Complete remission in two pediatric patients.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|